Clinical Trials Directory

Trials / Completed

CompletedNCT00668876

Effects of Immunonutrition in Patients Undergoing Pancreaticoduodenectomy

Effects of Immunonutrition on Surgical Site Infection and Th1/Th2/Th17 Differentiation in Patients Undergoing Pancreaticoduodenectomy

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Chiba University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether immunonutrition is effective on surgical site infection and Th1/Th2/Th17 differentiation in patients undergoing pancreaticoduodenectomy

Detailed description

Perioperative immunonutrition is reported to improve the incidence of postoperative infectious complication in patients with gastrointestinal surgery. It has also been recognized that Th1/Th2 balance shifts toward Th2 by surgical stress. On the other hand, the change of Th17 status after surgery has not been established. Furthermore, The change of Th1/Th2 balance and Th17 status with immunonutrition on pancreaticoduodenectomy have not been reported yet. Objective of this study is to investigate the effects of perioperative immunonutrition on incidence of postoperative infectious complication, Th1/Th2 balance and Th17 status after pancreaticoduodenectomy.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTOral IMPACToral supplementation for 5 days(1 L/d )before surgery of a formula enriched with arginine, omega-3 fatty acids, and RNA
DIETARY_SUPPLEMENTOral IMPACTpostoperative enteral infusion of the formula with arginine, omega-3 fatty acids, and RNA
DIETARY_SUPPLEMENTParenteral nutritionParenteral nutrition

Timeline

Start date
2006-05-01
Primary completion
2008-01-01
Completion
2008-09-01
First posted
2008-04-29
Last updated
2008-12-03

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT00668876. Inclusion in this directory is not an endorsement.